Interpace Biosciences (IDXG) Reports Q3 EPS of $0.04

Interpace Biosciences (OTC: IDXG) reported Q3 EPS of $0.04. Revenue for the quarter came in at $8.76 million.

For earnings history and earnings-related data on Interpace Biosciences (IDXG) click here.

You May Also Be Interested In

• onsemi downgraded by TD Cowen after Synaptics deal clouds growth story
• Benchmark Reiterates Buy Rating on NANO Nuclear Energy (NNE) Following CTO Termination
• UBS Reiterates Buy Rating on Teva Pharma (TEVA) as Pipeline Opportunities Broaden